EGF and IGF-I synergistically stimulate proliferation of human esophageal epithelial cells

Faisal G. Qureshi, Marcin T. Tchorzewski, Mark D. Duncan, John W. Harmon

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Proliferation of esophageal mucosal cells is important in repair of reflux-induced injury. We studied the effects of EGF, IGF-I, and IGF- I/binding protein-3 (BP-3) complex on immortalized esophageal epithelial (HET-1A) cells and searched for synergy between the growth factors. HET-1A cells were plated at 5 x 104 in 12 well plates. After 2 days in optimal media, they were maintained in basal media with or without the test peptides: EGF at 0.05-5 nM, IGF-I at 0.1-10 nM, IGF-I/BP-3 at 0.1-10 nM, and a combination of EGF at 5 nM and IGF-I or IGF-I/BP-3 at 1 and 10 nM. In comparison to basal media EGF and IGF-I stimulated cell proliferation over baseline at 5 and 10 nM, respectively. The combination of EGF at 5 nM and IGF-I at 1 and 10 nM worked synergistically, increasing cell counts over baseline to 10.3 ± 0.2 and 14.6 ± 0.8 x 105, respectively. The calculated additive effect of EGF and IGF-I at 1 and 10 nM individually increased cell counts to 8.2 ± 0.2 and 10.4 ± 0.6 x 105, respectively. The difference between the observed and the calculated values was significant at P < 0.05, ANOVA, Tukey test. IGF-I/BP-3 complex enhanced this synergy at low levels of IGF-I but not at 10 nM IGF-I. EGF, IGF, and IGF-I/BP-3 independently promote HET-1A proliferation. IGF and EGF in combination demonstrate synergism with potentiated interaction presumably because of their different roles in the cell cycle, EGF being a competence factor and IGF being a progression factor. This combination may have potential as a treatment for esophageal mucosal injury, and IGF-I/BP-3 may further enhance their benefit.

Original languageEnglish (US)
Pages (from-to)354-358
Number of pages5
JournalJournal of Surgical Research
Volume69
Issue number2
DOIs
StatePublished - Jan 1 1997

Fingerprint

Insulin-Like Growth Factor I
Epidermal Growth Factor
Epithelial Cells
Insulin-Like Growth Factor Binding Protein 3
Cell Count
Wounds and Injuries
Mental Competency
Intercellular Signaling Peptides and Proteins
Analysis of Variance
Cell Cycle
Cell Proliferation

ASJC Scopus subject areas

  • Surgery

Cite this

EGF and IGF-I synergistically stimulate proliferation of human esophageal epithelial cells. / Qureshi, Faisal G.; Tchorzewski, Marcin T.; Duncan, Mark D.; Harmon, John W.

In: Journal of Surgical Research, Vol. 69, No. 2, 01.01.1997, p. 354-358.

Research output: Contribution to journalArticle

Qureshi, Faisal G. ; Tchorzewski, Marcin T. ; Duncan, Mark D. ; Harmon, John W. / EGF and IGF-I synergistically stimulate proliferation of human esophageal epithelial cells. In: Journal of Surgical Research. 1997 ; Vol. 69, No. 2. pp. 354-358.
@article{3edd5a6b37c0453cbb09259c75267a39,
title = "EGF and IGF-I synergistically stimulate proliferation of human esophageal epithelial cells",
abstract = "Proliferation of esophageal mucosal cells is important in repair of reflux-induced injury. We studied the effects of EGF, IGF-I, and IGF- I/binding protein-3 (BP-3) complex on immortalized esophageal epithelial (HET-1A) cells and searched for synergy between the growth factors. HET-1A cells were plated at 5 x 104 in 12 well plates. After 2 days in optimal media, they were maintained in basal media with or without the test peptides: EGF at 0.05-5 nM, IGF-I at 0.1-10 nM, IGF-I/BP-3 at 0.1-10 nM, and a combination of EGF at 5 nM and IGF-I or IGF-I/BP-3 at 1 and 10 nM. In comparison to basal media EGF and IGF-I stimulated cell proliferation over baseline at 5 and 10 nM, respectively. The combination of EGF at 5 nM and IGF-I at 1 and 10 nM worked synergistically, increasing cell counts over baseline to 10.3 ± 0.2 and 14.6 ± 0.8 x 105, respectively. The calculated additive effect of EGF and IGF-I at 1 and 10 nM individually increased cell counts to 8.2 ± 0.2 and 10.4 ± 0.6 x 105, respectively. The difference between the observed and the calculated values was significant at P < 0.05, ANOVA, Tukey test. IGF-I/BP-3 complex enhanced this synergy at low levels of IGF-I but not at 10 nM IGF-I. EGF, IGF, and IGF-I/BP-3 independently promote HET-1A proliferation. IGF and EGF in combination demonstrate synergism with potentiated interaction presumably because of their different roles in the cell cycle, EGF being a competence factor and IGF being a progression factor. This combination may have potential as a treatment for esophageal mucosal injury, and IGF-I/BP-3 may further enhance their benefit.",
author = "Qureshi, {Faisal G.} and Tchorzewski, {Marcin T.} and Duncan, {Mark D.} and Harmon, {John W.}",
year = "1997",
month = "1",
day = "1",
doi = "10.1006/jsre.1997.5080",
language = "English (US)",
volume = "69",
pages = "354--358",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - EGF and IGF-I synergistically stimulate proliferation of human esophageal epithelial cells

AU - Qureshi, Faisal G.

AU - Tchorzewski, Marcin T.

AU - Duncan, Mark D.

AU - Harmon, John W.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Proliferation of esophageal mucosal cells is important in repair of reflux-induced injury. We studied the effects of EGF, IGF-I, and IGF- I/binding protein-3 (BP-3) complex on immortalized esophageal epithelial (HET-1A) cells and searched for synergy between the growth factors. HET-1A cells were plated at 5 x 104 in 12 well plates. After 2 days in optimal media, they were maintained in basal media with or without the test peptides: EGF at 0.05-5 nM, IGF-I at 0.1-10 nM, IGF-I/BP-3 at 0.1-10 nM, and a combination of EGF at 5 nM and IGF-I or IGF-I/BP-3 at 1 and 10 nM. In comparison to basal media EGF and IGF-I stimulated cell proliferation over baseline at 5 and 10 nM, respectively. The combination of EGF at 5 nM and IGF-I at 1 and 10 nM worked synergistically, increasing cell counts over baseline to 10.3 ± 0.2 and 14.6 ± 0.8 x 105, respectively. The calculated additive effect of EGF and IGF-I at 1 and 10 nM individually increased cell counts to 8.2 ± 0.2 and 10.4 ± 0.6 x 105, respectively. The difference between the observed and the calculated values was significant at P < 0.05, ANOVA, Tukey test. IGF-I/BP-3 complex enhanced this synergy at low levels of IGF-I but not at 10 nM IGF-I. EGF, IGF, and IGF-I/BP-3 independently promote HET-1A proliferation. IGF and EGF in combination demonstrate synergism with potentiated interaction presumably because of their different roles in the cell cycle, EGF being a competence factor and IGF being a progression factor. This combination may have potential as a treatment for esophageal mucosal injury, and IGF-I/BP-3 may further enhance their benefit.

AB - Proliferation of esophageal mucosal cells is important in repair of reflux-induced injury. We studied the effects of EGF, IGF-I, and IGF- I/binding protein-3 (BP-3) complex on immortalized esophageal epithelial (HET-1A) cells and searched for synergy between the growth factors. HET-1A cells were plated at 5 x 104 in 12 well plates. After 2 days in optimal media, they were maintained in basal media with or without the test peptides: EGF at 0.05-5 nM, IGF-I at 0.1-10 nM, IGF-I/BP-3 at 0.1-10 nM, and a combination of EGF at 5 nM and IGF-I or IGF-I/BP-3 at 1 and 10 nM. In comparison to basal media EGF and IGF-I stimulated cell proliferation over baseline at 5 and 10 nM, respectively. The combination of EGF at 5 nM and IGF-I at 1 and 10 nM worked synergistically, increasing cell counts over baseline to 10.3 ± 0.2 and 14.6 ± 0.8 x 105, respectively. The calculated additive effect of EGF and IGF-I at 1 and 10 nM individually increased cell counts to 8.2 ± 0.2 and 10.4 ± 0.6 x 105, respectively. The difference between the observed and the calculated values was significant at P < 0.05, ANOVA, Tukey test. IGF-I/BP-3 complex enhanced this synergy at low levels of IGF-I but not at 10 nM IGF-I. EGF, IGF, and IGF-I/BP-3 independently promote HET-1A proliferation. IGF and EGF in combination demonstrate synergism with potentiated interaction presumably because of their different roles in the cell cycle, EGF being a competence factor and IGF being a progression factor. This combination may have potential as a treatment for esophageal mucosal injury, and IGF-I/BP-3 may further enhance their benefit.

UR - http://www.scopus.com/inward/record.url?scp=0031147784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031147784&partnerID=8YFLogxK

U2 - 10.1006/jsre.1997.5080

DO - 10.1006/jsre.1997.5080

M3 - Article

C2 - 9224406

AN - SCOPUS:0031147784

VL - 69

SP - 354

EP - 358

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 2

ER -